Evidation, the leader in direct-to-participant real-world data and health research, today announced the appointment of Dr. Ghazanfar Khan as Chief Medical Officer.
Is the first pill just the beginning? For many children diagnosed with attention-deficit/hyperactivity disorder, a ...
AstraZeneca’s New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and Drug Administration (FDA) in the US for the treatment of adult patients with ...